The 5th U.S. Circuit Court of Appeals has delivered a setback to the Deferred Action for Childhood Arrivals (DACA) program, rejecting President Joe Biden’s effort to solidify protections for Dreamers.
House Democrats are opposing President-elect Donald Trump's proposed tariff increases. Representatives Suzan DelBene (D-WA) and Don Beyer (D-VA), joined by 11 other Democrats, introduced...
The suspect accused of starting a devastating Los Angeles wildfire is an illegal alien with a history of multiple encounters with law enforcement, according to Breitbart Editor-in-Chief Alex Marlow during Thursday’s Alex Marlow Show. The incident raises renewed questions about immigration enforcement and public safety.
Attorneys General from 20 states are calling on the U.S. Senate to quickly confirm three nominees proposed by President-elect Donald Trump for key national security positions. The nominees include Governor Kristi Noem (R-SD) for Secretary of Homeland Security, Pam Bondi for Attorney General, and Kash Patel for FBI Director. The officials emphasize the urgency of assembling a strong national security team given current challenges.
Republican lawmakers have introduced legislation to reestablish the Migrant Protection Protocols (MPP), commonly known as the "Remain in Mexico" policy.
On Wednesday, Democratic Governor Maura Healey proposed new restrictions to Massachusetts' decades-old right-to-shelter law, aiming to address rising concerns about criminal activity and fiscal strain within the state's emergency shelter system.
The Vatican City State has enacted stricter penalties for unauthorized entry and violations of its security regulations, threatening offenders with steep fines and prison sentences. The updated rules were announced through a decree signed by Cardinal Fernando Vérgez Alzaga, president of the Pontifical Commission for Vatican City State, and aim to enhance security within the world’s smallest sovereign state.
The Pharmacy Benefit Managers (PBMs) marked up the cost of some prescription drugs by 1,000%, according to a report from the Federal Trade Commission (FTC). Some of the drugs with significant price jumps included those for HIV and cancer.
